A new Stanford study found that women who used estrogen-only hormone therapy had 35% lower odds of Alzheimer's-related brain changes and 39% lower odds of a dementia diagnosis. The study is observational, so it shows a connection, not proof that estrogen prevents dementia, and it applies specifically to estrogen-only therapy, not the combined estrogen-progesterone therapy most menopausal women take.
If you've spent any time weighing whether to start hormone therapy, you've run into two very different stories about it. One says it protects you. One says it puts you at risk.
This week added a real piece of evidence to that conversation. It's worth understanding what it found, and what it didn't.
What the Stanford Study Actually Found
Researchers at Stanford Medicine analyzed data from two large groups: an autopsy cohort and a living participant cohort. In the autopsy data, women who had used estrogen-only hormone therapy showed 35% lower odds of the brain changes associated with Alzheimer's disease, things like amyloid plaques and neurofibrillary tangles, compared to women who never used it.
In the separate living cohort, women with a history of estrogen-only therapy had 39% lower odds of receiving a clinical dementia diagnosis during their lifetime. The study was published in the journal Neurology on August 12, 2026, and it's the first to directly measure the link between hormone therapy and Alzheimer's pathology in autopsied brain tissue, rather than relying only on diagnosis records.
Those are strong numbers. They're also the kind of numbers that get flattened the moment they leave the research world.
Your decision about hormone therapy is worth more than a headline. It's worth understanding exactly what this study can and can't tell you.
Why Observational Doesn't Mean Proven
This is an observational study. Researchers looked at women who had already made their own choices about hormone therapy and tracked what happened to them over time. Nobody was randomly assigned to take estrogen or not.
That matters because women who choose hormone therapy and women who don't may differ in other ways that also affect dementia risk. Access to care, general health habits, other medical conditions, even the reasons a woman was or wasn't prescribed estrogen in the first place, could all be doing part of the work behind these numbers. The study's own authors are careful to say the findings show an association, not a proven cause.
That doesn't make the finding meaningless. It means it's one solid data point in a much longer research process, not a final verdict you can act on with certainty.
Estrogen-Only Versus Combined Hormone Therapy: A Distinction That Matters
Here's the detail most coverage of this study will skip entirely. The researchers looked specifically at estrogen-only hormone therapy. That formulation is typically prescribed to women who no longer have a uterus, most often after a hysterectomy, because estrogen alone can increase the risk of uterine cancer in women who still have one.
Most women going through menopause still have a uterus, and they're prescribed combined estrogen and progesterone therapy instead. This study does not tell us whether the same brain benefit applies to combined therapy. Combined therapy has a different risk and benefit profile altogether, and lumping the two together, which is exactly what a lot of headline coverage will do, misrepresents what the research actually measured.
If you're reading a summary of this study anywhere else this week, this is the first question worth asking: estrogen-only, or combined?
When This Research Might Be Relevant to You
This finding may be worth discussing with your doctor when:
- You've had a hysterectomy and are already a candidate for estrogen-only therapy for symptom relief.
- You're early in perimenopause or menopause, since most of the supporting research, including this study, involves women who started treatment near the beginning of the transition.
- You have a family history of Alzheimer's disease and want every relevant data point on the table before deciding.
This finding tells you less than it might seem when:
- You still have a uterus and are considering combined estrogen-progesterone therapy, since that formulation wasn't the one studied here.
- You're more than ten years past your final period, since timing appears to change the risk-benefit picture and this study doesn't isolate that variable cleanly.
- You're looking for a guarantee, since an observational study, however well designed, can't provide one.
Either way, the honest answer depends on your labs, your history, and where you actually are in your transition, not on a single study written for a general audience of millions of different women.
A Few Things Worth Knowing Before You Talk to Your Doctor About Hormone Therapy
Bringing the right information into that conversation changes how useful it can be.
Get actual hormone testing done first. A conversation about hormone therapy is more productive when it starts from real lab data, not just symptoms. Full hormone panels, not just a single estrogen number, give a clearer picture of where you stand.
Bring your family history. Alzheimer's disease, breast cancer, and cardiovascular disease all factor into whether hormone therapy makes sense for you specifically. Your doctor can't weigh what they don't know.
Ask about timing, not just yes or no. The research increasingly suggests that when you start hormone therapy relative to menopause matters as much as whether you start it at all. That's a more useful question than a blanket should I or shouldn't I.
Separate the marketing from the research. Supplement companies, wellness brands, and even some clinics will use headlines like this one to sell products or programs that go well beyond what the study supports. A single observational study is not a blanket endorsement of every estrogen product on the market.
Ready to Figure Out Whether Hormone Therapy Makes Sense for You?
A study like this one is a useful data point, not a decision. The actual answer depends on your labs, your history, and your specific transition, which is exactly the kind of evaluation a one-size-fits-all headline can't do.
Frequently Asked Questions
Does hormone therapy protect against Alzheimer's disease?
A 2026 Stanford study found that women who used estrogen-only hormone therapy had 35% lower odds of Alzheimer's-related brain changes and 39% lower odds of a dementia diagnosis. The study shows a connection, not proof that hormone therapy prevents Alzheimer's, since it was observational rather than a controlled trial.
What's the difference between estrogen-only and combined hormone therapy?
Estrogen-only therapy is typically prescribed to women without a uterus, most often after a hysterectomy. Combined estrogen-progesterone therapy is prescribed to women who still have a uterus, because progesterone protects against the increased uterine cancer risk that estrogen alone can cause. The Stanford Alzheimer's study looked only at estrogen-only therapy.
Does the timing of starting hormone therapy matter?
Research, including this study, suggests that starting hormone therapy closer to the beginning of menopause is associated with better outcomes than starting it many years afterward. This is sometimes called the timing hypothesis, and it's an active area of ongoing research.
Is this study enough evidence to start hormone therapy for brain health alone?
Not on its own. It's one observational study, and it applies specifically to estrogen-only therapy. Any decision about hormone therapy should factor in your full hormone panel, personal and family health history, and your specific menopause symptoms, not one data point.
Where was this study published?
The study was published in the journal Neurology on August 12, 2026, based on research from Stanford Medicine using autopsy data and a separate living participant cohort.
How do I find out if hormone therapy is right for me?
The most reliable way is a full evaluation that includes comprehensive hormone lab testing, a review of your personal and family health history, and a conversation about where you are in your menopause transition. A discovery call is a good place to start that conversation.
Dr. Erin Ellis, ND
Dr. Erin Ellis, ND, is the founder of Hope Natural Health and a licensed Naturopathic Doctor with more than nine years of clinical experience specializing in women's hormone health. After overcoming cancer, Dr. Ellis made it her life's mission to help women find the root cause of why they don't feel like themselves. She believes "normal" lab results are only the beginning of the conversation - not the end - and is known for taking a deeper, investigative approach to hormone, thyroid, gut, and metabolic health.